Sagentia, a global innovation, technology and product development
company, today announced that their United States headquarters has moved
from the Cambridge Innovation Center in Cambridge, Mass. to One Beacon
Street in Boston. Sagentia develops new technologies and breakthrough
products that help change the basis of competition for its clients, from
startups to global leaders in three global sectors: medical, consumer
products and industrial. The new office, over 3 times larger than their
previous space, will give Sagentia the room needed to continue to grow
their presence in the U.S.
"The relocation to Boston places Sagentia in close proximity to a wealth
of world-renowned university research hospitals, which will provide a
rich environment to help the company grow," said Peter Thier, senior
vice president of business development at Sagentia. "Massachusetts has a
thriving life sciences industry, and Sagentia is thrilled to continue to
play a vital role in that community."
The move comes on the heels of particularly strong customer growth in
North America, providing Sagentia the opportunity to continue to be a
strong leader in product innovation, science and technology consulting
and product development. Particularly in today's economy, Sagentia's
ability to bridge market needs with viable concept generation, proof of
principle demonstrators and prototyping is an nvaluable service to its
"We are pleased that Sagentia is continuing to grow their presence in
Massachusetts," said Ann Merrifield, chief executive officer of
PathoGenetix, developer of an automated system for rapid identification
of bacterial strains. "As PathoGenetix prepares to launch its Genome
Sequence Scanning technology, we are fortunate to have a critical
partner in its commercialization located in our own backyard. Having a
team that understands our core objectives so easily accessible is a huge
"Sagentia's ability to combine theoretical modeling, product design and
prototyping are key as an R&D partner," said Stephen Trotta, Vice
President of R&D Instrument Development at Instrumentation Laboratory.
"We are happy to hear about their growth in the US with this move to
Boston and look forward to hearing about their continued success."
Sagentia responds to its clients' needs in three important ways: helping
companies meet the challenges of product innovation as the core driver
for competitive advantage in both developed and developing markets,
partnering with companies on co-development and open innovation and
helping companies to adapt to global market changes with an increasing
focus on usability, product efficacy, personalization and cost reduction.
This announcement follows a recent change in Sagentia's leadership, with
Dan Edwards and Mick Withers appointed as co-Managing Directors of the
business. The change takes place as Sagentia continues to build on its
strong science, technology and engineering base with focused market
insight to meet the growing needs of its clients.
Sagentia is a global innovation, technology and product development
company. We provide outsourced R&D consultancy services to start ups
through to global market leaders in the medical, industrial and consumer
sectors. With global headquarters in Cambridge, UK, and US headquarters
in Boston, Massachusetts, Sagentia works with clients from opportunity
discovery through to concept generation and full product development and
transfer to manufacture. We deliver science and technology innovation
and work with clients to develop next generation products and services
that provide commercial value and market advantage. Further information
can be found at: http://www.sagentia.com.
Email us firstname.lastname@example.org
[ Back To NFVZone's Homepage ]